A387570 Stock Overview

Manufactures and sells medical devices in South Korea. More details

A387570 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap (₩66B)

Profit margins (1%) are lower than last year (9.7%)

My Notes

Capture your thoughts, links and company narrative

Finemedix Co., Ltd. Competitors

DRGEM

KOSDAQ:A263690

₩63.4b

Genoray

KOSDAQ:A122310

₩72.7b

ASTA

KOSDAQ:A246720

₩62.7b

Huvitz

KOSDAQ:A065510

₩90.1b

Price History & Performance

Summary of share price highs, lows and changes for Finemedix
Historical stock prices
Current Share Price	₩12,200.00
52 Week High	₩27,000.00
52 Week Low	₩12,030.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-23.75%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	A387570	KR Medical Equipment	KR Market
7D	-15.3%	8.1%	4.2%
1Y	n/a	4.7%	-6.0%

Return vs Industry: Insufficient data to determine how A387570 performed against the KR Medical Equipment industry.

Return vs Market: Insufficient data to determine how A387570 performed against the KR Market.

Price Volatility

Is A387570's price volatile compared to industry and market?
A387570 volatility
A387570 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.7%
10% most volatile stocks in KR Market	12.8%
10% least volatile stocks in KR Market	3.4%

Stable Share Price: A387570's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A387570's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Seong-Woo Jeon	www.finemedix.com

Finemedix Co., Ltd. manufactures and sells medical devices in South Korea. It offers knives; polypectomy and EMR snares and retrieval nets; hemostatic forceps, injection catheters, hemoclips, coagulation probes, and clearcoajets; and biopsy products, such as disposable, disposable, reusable, and hot biopsy forceps. The company also provides EUS/EBUS products; ERCP baskets and cannulas, and sphincterotomes; and accessories, including distal caps, mouth pieces, and other products.

Finemedix Co., Ltd. Fundamentals Summary

How do Finemedix's earnings and revenue compare to its market cap?
A387570 fundamental statistics
Market cap	₩66.25b
Earnings (TTM)	₩95.62m
Revenue (TTM)	₩9.28b

692.9x

P/E Ratio

7.1x

P/S Ratio

Is A387570 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A387570 income statement (TTM)
Revenue	₩9.28b
Cost of Revenue	₩4.06b
Gross Profit	₩5.23b
Other Expenses	₩5.13b
Earnings	₩95.62m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	17.61
Gross Margin	56.30%
Net Profit Margin	1.03%
Debt/Equity Ratio	30.4%

How did A387570 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 23:55
End of Day Share Price	2025/01/08 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Finemedix Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution